Growth Metrics

Steris (STE) Cash & Equivalents (2017 - 2025)

Historic Cash & Equivalents for Steris (STE) over the last 9 years, with Q4 2025 value amounting to $423.7 million.

  • Steris' Cash & Equivalents rose 17304.13% to $423.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $423.7 million, marking a year-over-year increase of 17304.13%. This contributed to the annual value of $171.7 million for FY2025, which is 1706.12% down from last year.
  • Steris' Cash & Equivalents amounted to $423.7 million in Q4 2025, which was up 17304.13% from $319.2 million recorded in Q3 2025.
  • In the past 5 years, Steris' Cash & Equivalents ranged from a high of $534.8 million in Q2 2021 and a low of $155.2 million during Q4 2024
  • For the 5-year period, Steris' Cash & Equivalents averaged around $271.7 million, with its median value being $239.4 million (2021).
  • In the last 5 years, Steris' Cash & Equivalents crashed by 4084.85% in 2022 and then skyrocketed by 17304.13% in 2025.
  • Over the past 5 years, Steris' Cash & Equivalents (Quarter) stood at $359.1 million in 2021, then decreased by 27.77% to $259.4 million in 2022, then decreased by 24.59% to $195.6 million in 2023, then decreased by 20.66% to $155.2 million in 2024, then skyrocketed by 173.04% to $423.7 million in 2025.
  • Its last three reported values are $423.7 million in Q4 2025, $319.2 million for Q3 2025, and $279.7 million during Q2 2025.